Works by Rosiñol, Laura

Results: 103
    1
    2
    3
    4
    5
    6
    7

    Expression of p53 protein isoforms predicts survival in patients with multiple myeloma.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 6, p. 700, doi. 10.1002/ajh.26507
    By:
    • Rojas, Elizabeta A.;
    • Corchete, Luis A.;
    • De Ramón, Cristina;
    • Krzeminski, Patryk;
    • Quwaider, Dalia;
    • García‐Sanz, Ramón;
    • Martínez‐López, Joaquín;
    • Oriol, Albert;
    • Rosiñol, Laura;
    • Bladé, Joan;
    • Lahuerta, Juan José;
    • San Miguel, Jesús F.;
    • González, Marcos;
    • Mateos, María Victoria;
    • Bourdon, Jean‐Christophe;
    • Misiewicz‐Krzeminska, Irena;
    • Gutiérrez, Norma C.
    Publication type:
    Article
    8

    A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 5, p. 503, doi. 10.1002/ajh.25758
    By:
    • Goldman‐Mazur, Sarah;
    • Jurczyszyn, Artur;
    • Castillo, Jorge J.;
    • Waszczuk‐Gajda, Anna;
    • Grząśko, Norbert;
    • Radocha, Jakub;
    • Bittrich, Max;
    • Kortüm, K. Martin;
    • Gozzetti, Alessandro;
    • Usnarska‐Zubkiewicz, Lidia;
    • Davila Valls, Julio;
    • Jayabalan, David S.;
    • Niesvizky, Ruben;
    • Kelman, Julia;
    • Coriu, Daniel;
    • Rosiñol, Laura;
    • Szukalski, Łukasz;
    • González‐Calle, Veronica;
    • Mateos, Maria V.;
    • Jamroziak, Krzysztof
    Publication type:
    Article
    9

    Patient‐reported health‐related quality of life from the phase III TOURMALINE‐MM1 study of ixazomib‐lenalidomide‐dexamethasone versus placebo‐lenalidomide‐dexamethasone in relapsed/refractory multiple myeloma.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 8, p. 985, doi. 10.1002/ajh.25134
    By:
    • Leleu, Xavier;
    • Masszi, Tamas;
    • Bahlis, Nizar J.;
    • Viterbo, Luisa;
    • Baker, Bartrum;
    • Gimsing, Peter;
    • Maisnar, Vladimir;
    • Samoilova, Olga;
    • Rosiñol, Laura;
    • Langer, Christian;
    • Song, Kevin;
    • Izumi, Tohru;
    • Cleeland, Charles;
    • Berg, Deborah;
    • Lin, Huamao Mark;
    • Zhu, Yanyan;
    • Skacel, Tomas;
    • Moreau, Philippe;
    • Richardson, Paul G.
    Publication type:
    Article
    10

    Lymphoplasmacytic lymphoma causing light chain cast nephropathy.

    Published in:
    Nephrology Dialysis Transplantation, 2012, v. 27, n. 1, p. 450, doi. 10.1093/ndt/gfr730
    By:
    • Pérez, Nuria S.;
    • Garcia-Herrera, Adriana;
    • Rosiñol, Laura;
    • Palos, Lily;
    • Santiago, Evelyn;
    • Espinosa, Gerard;
    • Solé, Manel;
    • Campistol, Josep M.;
    • Quintana, Luis F.
    Publication type:
    Article
    11

    Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00805-x
    By:
    • Moreau, Philippe;
    • Chari, Ajai;
    • Oriol, Albert;
    • Martinez-Lopez, Joaquin;
    • Haenel, Mathias;
    • Touzeau, Cyrille;
    • Ailawadhi, Sikander;
    • Besemer, Britta;
    • de la Rubia Comos, Javier;
    • Encinas, Cristina;
    • Mateos, Maria-Victoria;
    • Salwender, Hans;
    • Rodriguez-Otero, Paula;
    • Hulin, Cyrille;
    • Karlin, Lionel;
    • Sureda Balari, Anna;
    • Bargay, Joan;
    • Benboubker, Lotfi;
    • Rosiñol, Laura;
    • Tarantolo, Stefano
    Publication type:
    Article
    12

    Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

    Published in:
    2023
    By:
    • Moreau, Philippe;
    • Chari, Ajai;
    • Oriol, Albert;
    • Martinez-Lopez, Joaquin;
    • Haenel, Mathias;
    • Touzeau, Cyrille;
    • Ailawadhi, Sikander;
    • Besemer, Britta;
    • de la Rubia Comos, Javier;
    • Encinas, Cristina;
    • Mateos, Maria-Victoria;
    • Salwender, Hans;
    • Rodriguez-Otero, Paula;
    • Hulin, Cyrille;
    • Karlin, Lionel;
    • Sureda Balari, Anna;
    • Bargay, Joan;
    • Benboubker, Lotfi;
    • Rosiñol, Laura;
    • Tarantolo, Stefano
    Publication type:
    Letter
    13
    14

    Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00647-z
    By:
    • Mosquera Orgueira, Adrian;
    • González Pérez, Marta Sonia;
    • Diaz Arias, Jose;
    • Rosiñol, Laura;
    • Oriol, Albert;
    • Teruel, Ana Isabel;
    • Martinez Lopez, Joaquin;
    • Palomera, Luis;
    • Granell, Miguel;
    • Blanchard, Maria Jesus;
    • de la Rubia, Javier;
    • López de la Guia, Ana;
    • Rios, Rafael;
    • Sureda, Anna;
    • Hernandez, Miguel Teodoro;
    • Bengoechea, Enrique;
    • Calasanz, María José;
    • Gutierrez, Norma;
    • Martin, Maria Luis;
    • Blade, Joan
    Publication type:
    Article
    15

    A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00652-2
    By:
    • Encinas, Cristina;
    • Hernandez-Rivas, José-Ángel;
    • Oriol, Albert;
    • Rosiñol, Laura;
    • Blanchard, María-Jesús;
    • Bellón, José-María;
    • García-Sanz, Ramón;
    • de la Rubia, Javier;
    • de la Guía, Ana López;
    • Jímenez-Ubieto, Ana;
    • Jarque, Isidro;
    • Iñigo, Belén;
    • Dourdil, Victoria;
    • de Arriba, Felipe;
    • Pérez-Ávila, Clara Cuéllar;
    • Gonzalez, Yolanda;
    • Hernández, Miguel-Teodoro;
    • Bargay, Joan;
    • Granell, Miguel;
    • Rodríguez-Otero, Paula
    Publication type:
    Article
    16
    17

    Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00587-0
    By:
    • Fernández de Larrea, Carlos;
    • Kyle, Robert;
    • Rosiñol, Laura;
    • Paiva, Bruno;
    • Engelhardt, Monika;
    • Usmani, Saad;
    • Caers, Jo;
    • Gonsalves, Wilson;
    • Schjesvold, Fredrik;
    • Merlini, Giampaolo;
    • Lentzch, Suzanne;
    • Ocio, Enrique;
    • Garderet, Laurent;
    • Moreau, Philippe;
    • Sonneveld, Pieter;
    • Badros, Ashraf;
    • Gahrton, Gösta;
    • Goldschmidt, Hartmut;
    • Tuchman, Sascha;
    • Einsele, Hermann
    Publication type:
    Article
    18

    Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00490-8
    By:
    • Puig, Noemi;
    • Hernández, Miguel T.;
    • Rosiñol, Laura;
    • González, Esther;
    • de Arriba, Felipe;
    • Oriol, Albert;
    • González-Calle, Verónica;
    • Escalante, Fernando;
    • de la Rubia, Javier;
    • Gironella, Mercedes;
    • Ríos, Rafael;
    • García-Sánchez, Ricarda;
    • Arguiñano, José M.;
    • Alegre, Adrián;
    • Martín, Jesús;
    • Gutiérrez, Norma. C.;
    • Calasanz, María J.;
    • Martín, María L.;
    • Couto, María del Carmen;
    • Casanova, María
    Publication type:
    Article
    19

    Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation.

    Published in:
    Pharmaceuticals (14248247), 2024, v. 17, n. 5, p. 553, doi. 10.3390/ph17050553
    By:
    • Marco, Daniel N.;
    • Molina, Mònica;
    • Guio, Ana-María;
    • Julian, Judit;
    • Fortuna, Virginia;
    • Fabregat-Zaragoza, Virginia-Lucila;
    • Salas, María-Queralt;
    • Monge-Escartín, Inés;
    • Riu-Viladoms, Gisela;
    • Carcelero, Esther;
    • Roma, Joan Ramón;
    • Llobet, Noemí;
    • Arcarons, Jordi;
    • Suárez-Lledó, María;
    • Rosiñol, Laura;
    • Fernández-Avilés, Francesc;
    • Rovira, Montserrat;
    • Brunet, Mercè;
    • Martínez, Carmen
    Publication type:
    Article
    20

    Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide.

    Published in:
    Pharmaceuticals (14248247), 2022, v. 15, n. 12, p. 1529, doi. 10.3390/ph15121529
    By:
    • Marco, Daniel N.;
    • Salas, María Queralt;
    • Gutiérrez-García, Gonzalo;
    • Monge, Inés;
    • Riu, Gisela;
    • Carcelero, Esther;
    • Roma, Joan Ramón;
    • Llobet, Noemí;
    • Arcarons, Jordi;
    • Suárez-Lledó, María;
    • Martínez, Nuria;
    • Pedraza, Alexandra;
    • Domenech, Ariadna;
    • Rosiñol, Laura;
    • Fernández-Avilés, Francesc;
    • Urbano-Ispízua, Álvaro;
    • Rovira, Montserrat;
    • Brunet, Mercè;
    • Martínez, Carmen
    Publication type:
    Article
    21

    High‐risk features of early relapse in newly‐diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy.

    Published in:
    HemaSphere, 2025, v. 9, n. 4, p. 1, doi. 10.1002/hem3.70127
    By:
    • Manubens, Andrea;
    • Paiva, Bruno;
    • Gutiérrez, Norma C.;
    • Fernandez, Manuela;
    • Calasanz, Maria‐José;
    • Rosiñol, Laura;
    • Oriol, Albert;
    • Blanchard, Ma Jesús;
    • Carrillo, Estrella;
    • Benavente, Celina;
    • Martínez‐López, Joaquín;
    • Bargay, Joan;
    • Hernández, Miguel Teodoro;
    • de la Rubia, Javier;
    • González, Yolanda;
    • Paricio, Miguel;
    • de Arriba, Felipe;
    • Ocio, Enrique M.;
    • Teruel, Ana Isabel;
    • de la Guia, Ana López
    Publication type:
    Article
    22

    Expression profile of Bcl‐2 family proteins in newly diagnosed multiple myeloma patients.

    Published in:
    HemaSphere, 2024, v. 8, n. 12, p. 1, doi. 10.1002/hem3.70036
    By:
    • De Ramón, Cristina;
    • Rojas, Elizabeta A.;
    • Misiewicz‐Krzeminska, Irena;
    • Cardona‐Benavides, Ignacio J.;
    • Cuadrado, Myriam;
    • Isidro, Isabel;
    • Calasanz, María‐José;
    • Fernandez, Manuela;
    • García‐Sanz, Ramón;
    • Puig, Noemi;
    • Cedena, M. Teresa;
    • Paiva, Bruno;
    • Rosiñol, Laura;
    • Martínez‐López, Joaquín;
    • Bladé, Joan;
    • Lahuerta, Juan J.;
    • San Miguel, Jesús F.;
    • Mateos, María V.;
    • Corchete, Luis A.;
    • Gutiérrez, Norma C.
    Publication type:
    Article
    23

    High‐risk cytogenetic abnormalities in multiple myeloma: PETHEMA‐GEM experience.

    Published in:
    HemaSphere, 2024, v. 8, n. 12, p. 1, doi. 10.1002/hem3.70031
    By:
    • González‐Calle, Veronica;
    • Rodriguez‐Otero, Paula;
    • Calasanz, Maria J.;
    • Guijarro, Manuela;
    • Martínez‐López, Joaquin;
    • Rosiñol, Laura;
    • Hernández, Miguel T.;
    • Teruel, Ana I.;
    • Gironella, Mercedes;
    • Oriol, Albert;
    • de la Rubia, Javier;
    • González‐Rodríguez, Ana P.;
    • Bargay, Joan;
    • de Arriba, Felipe;
    • Palomera, Luis;
    • González‐Pérez, Marta‐Sonia;
    • Sureda, Anna;
    • Ocio, Enrique;
    • Lahuerta, Juan J.;
    • Bladé, Joan
    Publication type:
    Article
    24
    25

    S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM‐2 RESULTS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000967680.90062.ca
    By:
    • Bahlis, Nizar J;
    • Weisel, Katja;
    • Mateos, Maria‐Victoria;
    • Goldschmidt, Hartmut;
    • Martin, Tom;
    • Morillo, Daniel;
    • Reece, Donna;
    • Rodríguez‐Otero, Paula;
    • Bhutani, Manisha;
    • D’souza, Anita;
    • Oriol, Albert;
    • Rosiñol Dachs, Laura;
    • Dholaria, Bhagirathbhai;
    • Bakshi, Kalpana;
    • Kang, Lijuan;
    • Vandenberk, Lien;
    • Smit, Damiette;
    • Wäsch, Ralph;
    • van de Donk, Niels W.C.J.;
    • Chari, Ajai
    Publication type:
    Article
    26

    P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM).

    Published in:
    2023
    By:
    • Sidana, Surbhi;
    • Moreau, Philippe;
    • Garfall, Alfred;
    • Bhutani, Manisha;
    • Oriol, Albert;
    • Nooka, Ajay;
    • Martin, Tom;
    • Rosiñol Dachs, Laura;
    • Mateos, Maria-Victoria;
    • Bahlis, Nizar J;
    • Popat, Rakesh;
    • Besemer, Britta;
    • Martinez-Lopez, Joaquín;
    • Krishnan, Amrita;
    • Delforge, Michel;
    • Trancucci, Danielle;
    • Verona, Raluca;
    • Stephenson, Tara;
    • Chastain, Katherine;
    • van de Donk, Niels W.C.J.
    Publication type:
    Abstract
    27
    28

    P848: EXPRESSION PROFILE OF BCL-2 FAMILY PROTEINS IN MULTIPLE MYELOMA.

    Published in:
    2023
    By:
    • Sánchez, Cristina De Ramón;
    • Rojas, Elizabeta A;
    • Misiewicz-Krzeminska, Irena;
    • Cardona-Benavides, Ignacio J;
    • Cuadrado, Myriam;
    • Isidro, Isabel;
    • Jose Calasanz, Maria;
    • García-Sanz, Ramón;
    • Rosiñol Dachs, Laura;
    • Martinez-Lopez, Joaquín;
    • Baldé, Joan;
    • Lahuerta, Juan J;
    • San Miguel, Jesus F;
    • Mateos, Maria-Victoria;
    • Corchete, Luis A;
    • Gutierrez, Norma Carmen Gutierrez
    Publication type:
    Abstract
    29

    Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 11, p. 1847, doi. 10.1080/10428194.2023.2240922
    By:
    • Dachs, Laura Rosiñol;
    • Gaisán, Carmen Montes;
    • Bustamante, Gabriela;
    • López, Sebastián Garzón;
    • García, Esther González;
    • Persona, Ernesto Pérez;
    • González-Calle, Verónica;
    • Auzmendi, Maialen Sirvent;
    • Pérez, José Maria Arguiñano;
    • González Montes, Yolanda;
    • Ríos Tamayo, Rafael;
    • de Miguel Llorente, Dunia;
    • Bernal, Luis Palomera;
    • Mayol, Antonia Sampol;
    • Caro, Carmen Couto;
    • Grande, Marta;
    • Fernández-Nistal, Alonso;
    • Naves, Andrea;
    • Miguel, Enrique M. Ocio San
    Publication type:
    Article
    30

    Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM).

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 14, p. 3438, doi. 10.1080/10428194.2022.2123229
    By:
    • Villalba, Ana;
    • Gonzalez-Rodriguez, Ana Pilar;
    • Arzuaga-Mendez, Javier;
    • Puig, Noemí;
    • Arnao, Mario;
    • Arguiñano, José María;
    • Jimenez, María;
    • Canet, Marta;
    • Teruel, Ana I.;
    • Sola, María;
    • Díaz, Francisco J.;
    • Encinas, Cristina;
    • Garcia, Antonio;
    • Rosiñol, Laura;
    • Suárez, Alexia;
    • Gonzalez, Marta Sonia;
    • Izquierdo, Isabel;
    • Hernández, Miguel Teodoro;
    • Infante, María Stefania;
    • Sánchez, María José
    Publication type:
    Article
    31
    32

    Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 8, p. 1885, doi. 10.1080/10428194.2020.1749605
    By:
    • Goldman-Mazur, Sarah;
    • Jurczyszyn, Artur;
    • Castillo, Jorge J.;
    • Waszczuk-Gajda, Anna;
    • Grząśko, Norbert;
    • Radocha, Jakub;
    • Bittrich, Max;
    • Kortüm, Klaus Martin;
    • Gozzetti, Alessandro;
    • Usnarska-Zubkiewicz, Lidia;
    • Valls, Julio D.;
    • Jayabalan, David S.;
    • Niesvizky, Ruben;
    • Kelman, Julia;
    • Coriu, Daniel;
    • Rosiñol, Laura;
    • Szukalski, Łukasz;
    • González-Calle, Veronica;
    • Mateos, María-Victoria;
    • Jamroziak, Krzysztof
    Publication type:
    Article
    33

    Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1565, doi. 10.1080/10428194.2020.1742901
    By:
    • Rodríguez-Lobato, Luis Gerardo;
    • Martínez-Roca, Alexandra;
    • Moreno, David F.;
    • Gutiérrez-García, Gonzalo;
    • Suárez-Lledó, María;
    • Rovira, Montserrat;
    • Martínez, Carmen;
    • Rosiñol, Laura;
    • Almeida Jorge, Ana Sofía;
    • Pedraza, Alexandra;
    • Cardozo, Celia;
    • Puerta-Alcalde, Pedro;
    • Garcia-Vidal, Carolina;
    • Marín, Pedro;
    • Cid, Joan;
    • Lozano, Miquel;
    • Gallego, Cristina;
    • Hernando, Adelina;
    • Segura, Susana;
    • Urbano-Ispizua, Álvaro
    Publication type:
    Article
    34

    Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup.

    Published in:
    2017
    By:
    • Ludwig, Heinz;
    • Dimopoulos, Meletios A.;
    • Moreau, Philippe;
    • Chng, Wee-Joo;
    • Goldschmidt, Hartmut;
    • Hájek, Roman;
    • Facon, Thierry;
    • Pour, Ludek;
    • Niesvizky, Ruben;
    • Oriol, Albert;
    • Rosiñol, Laura;
    • Suvorov, Aleksandr;
    • Gaidano, Gianluca;
    • Pika, Tomas;
    • Weisel, Katja;
    • Goranova-Marinova, Vesselina;
    • Palumbo, Antonio;
    • Gillenwater, Heidi H.;
    • Mohamed, Nehal;
    • Aggarwal, Sanjay
    Publication type:
    Letter to the Editor
    35
    36
    37

    Clinical applicability and prognostic significance of molecular response assessed by fluorescent- PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/ PETHEMA study.

    Published in:
    British Journal of Haematology, 2013, v. 163, n. 5, p. 581, doi. 10.1111/bjh.12576
    By:
    • Martinez ‐ Lopez, Joaquin;
    • Fernández ‐ Redondo, Elena;
    • García ‐ Sánz, Ramón;
    • Montalbán, María Angeles;
    • Martínez ‐ Sánchez, Pilar;
    • Pavia, Bruno;
    • Mateos, María Victoria;
    • Rosiñol, Laura;
    • Martín, Marisa;
    • Ayala, Rosa;
    • Martínez, Rafael;
    • Blanchard, María Jesus;
    • Alegre, Adrian;
    • Besalduch, Joan;
    • Bargay, Joan;
    • Hernandez, Miguel T.;
    • Sarasquete, María Eugenia;
    • Sanchez ‐ Godoy, Pedro;
    • Fernández, Manuela;
    • Blade, Joan
    Publication type:
    Article
    38

    Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma.

    Published in:
    British Journal of Haematology, 2013, v. 163, n. 2, p. 223, doi. 10.1111/bjh.12519
    By:
    • Sarasquete, María E.;
    • Martínez‐López, Joaquín;
    • Chillón, María C.;
    • Alcoceba, Miguel;
    • Corchete, Luis A.;
    • Paiva, Bruno;
    • Puig, Noemi;
    • Sebastián, Elena;
    • Jiménez, Cristina;
    • Mateos, Maria‐Victoria;
    • Oriol, Albert;
    • Rosiñol, Laura;
    • Palomera, Luis;
    • Teruel, Ana I.;
    • González, Yolanda;
    • Lahuerta, Juan J.;
    • Bladé, Joan;
    • Gutiérrez, Norma C.;
    • Fernández‐Redondo, Elena;
    • González, Marcos
    Publication type:
    Article
    39

    Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen ( RIC) and post-allogeneic transplantation for high-risk myeloma patients.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 4, p. 474, doi. 10.1111/bjh.12410
    By:
    • Caballero‐Velázquez, Teresa;
    • López‐Corral, Lucia;
    • Encinas, Cristina;
    • Castilla‐Llorente, Cristina;
    • Martino, Rodrigo;
    • Rosiñol, Laura;
    • Sampol, Antonia;
    • Caballero, Dolores;
    • Serrano, David;
    • Heras, Inmaculada;
    • San Miguel, Jesús;
    • Pérez‐Simón, José A.
    Publication type:
    Article
    40

    The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma.

    Published in:
    British Journal of Haematology, 2008, v. 143, n. 1, p. 46, doi. 10.1111/j.1365-2141.2008.07303.x
    By:
    • Niesvizky, Ruben;
    • Richardson, Paul G.;
    • Rajkumar, S. Vincent;
    • Coleman, Morton;
    • Rosiñol, Laura;
    • Sonneveld, Pieter;
    • Schuster, Michael W.;
    • Irwin, David;
    • Stadtmauer, Edward A.;
    • Facon, Thierry;
    • Harousseau, Jean-Luc;
    • Boral, Anthony L.;
    • Esseltine, Dixie-Lee;
    • Anderson, Kenneth C.;
    • Blad, Joan
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 1020, doi. 10.1002/hon.3038
    By:
    • Facon, Thierry;
    • Moreau, Philippe;
    • Martin, Thomas G.;
    • Spicka, Ivan;
    • Oriol, Albert;
    • Koh, Youngil;
    • Lim, Andrew;
    • Mikala, Gabor;
    • Rosiñol, Laura;
    • Yağci, Münci;
    • Cavo, Michele;
    • Yong, Kwee;
    • Risse, Marie‐Laure;
    • Asset, Gaëlle;
    • Schwab, Sandrine;
    • Martinez, Gracia
    Publication type:
    Article